View the accessible transcript of this podcast
Professor Tim Maughan talks to Professor Allan Gaw about lessons learnt from delivering the world-renowned, molecularly stratified FOCUS4 platform trial He explains how this flagship trial was designed to respond to a need for a systematic approach to quickly understand which emerging, innovative cancer treatments worked against which cancers. He also describes why one of the biggest challenges was engaging life science companies. Finally he points to how this, and other ground-breaking cancer platform trials, have paved the way for COVID19 platform trials like RECOVERY which have saved thousands of lives around the globe.
This podcast is part of our 'Perspectives from the Pandemic' series looking at the delivery of Complex and Innovative Design (CID) trials in the COVID-19 pandemic. You can access the full series of #ComplexInnovativeDesign trial podcasts on our website: www.nihr.ac.uk/documents/delivering-complex-and-innovative-trials-podcast-collection/29517
To find out more about how the NIHR supports complex and innovative design trials visit: www.nihr.ac.uk/innovative-trials
